Assessment of Vulnerability to Carotid Stenosis by MultiModal Imaging and Cellular and Molecular Biology Analysis
NCT ID: NCT05190510
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
12 participants
OBSERVATIONAL
2022-02-14
2023-01-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For many years, only the degree of stenosis was used to assess the risk of stroke, based on the results of original studies from the 1990s. However, the significant improvement in medical treatments since then has significantly reduced the risk of stroke, and the benefits of carotid intervention are becoming increasingly debatable.
Since the publication of the latest recommendations, the degree of stenosis alone is no longer sufficient to propose an intervention, since most of them will never lead to a neurological event. In addition to stenosis greater than 60%, for the first time, other criteria must be sought to decide on treatment. For example, so-called carotid plaque "vulnerability" criteria, defining patients "at high risk of stroke," should be sought.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2
NCT05850247
Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control
NCT02748941
Comprehensive Assessment of Atherosclerotic Ischemic Stroke Risk and Development of a Prediction Model
NCT06315153
Carotid Plaque Characterization Using Innovative Ultrasound Techniques
NCT06804707
Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections
NCT00657969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with atheromatous stenosis of the internal carotid artery
Data collection
Collection of data from preoperative imaging examinations (routine examination prescribed before the operation)
collection of the carotid plaque (surgical specimen)
collection of the carotid plaque
anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens
anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Collection of data from preoperative imaging examinations (routine examination prescribed before the operation)
collection of the carotid plaque (surgical specimen)
collection of the carotid plaque
anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens
anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled surgery
Exclusion Criteria
* who did not have a preoperative CT angiogram of the supra-aortic trunks
* with contraindication to MRI
* with contraindication to PET scan
* with a history of cervical radiotherapy
* with uncontrolled diabetes
* with a previous homolateral carotid endarterectomy
* who has already undergone angioplasty-stenting of the homolateral carotid artery
* with a neoplasia considered active / not cured
* Surgical procedure performed in emergency
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STEINMETZ 2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.